(Q37301327)

19 August 2017

1 reference

title

Uterine papillary serous carcinoma: state of the state (English)

1 reference

19 August 2017

1 reference

R Wendel Naumann

1

1 reference

19 August 2017

1 November 2008

1 reference

19 August 2017

Current Oncology Reports

1 reference

19 August 2017

10

1 reference

19 August 2017

6

1 reference

19 August 2017

505-511

1 reference

https://scigraph.springernature.com/pub.10.1007/s11912-008-0076-x

19 August 2017

0 references

cites work

p53 expression in neoplasms of the uterine corpus.

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS11912-008-0076-X

Treatment of high-risk uterine cancer with whole abdominopelvic radiation therapy

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS11912-008-0076-X

Paclitaxel and carboplatin, alone or with irradiation, in advanced or recurrent endometrial cancer: a phase II study

21 January 2018

1 reference

12 December 2020

What staging surgery should be performed on patients with uterine papillary serous carcinoma?

1 reference

12 December 2020

The role of cytoreductive surgery in the management of stage IV uterine papillary serous carcinoma

1 reference

12 December 2020

Uterine papillary serous carcinoma: patterns of metastatic spread

1 reference

12 December 2020

Treatment of uterine papillary serous carcinoma with platinum-based chemotherapy and paclitaxel

1 reference

12 December 2020

Treatment of uterine papillary serous carcinoma with paclitaxel

1 reference

12 December 2020

Endometrial glandular dysplasia: a newly defined precursor lesion of uterine papillary serous carcinoma. Part I: morphologic features

1 reference

12 December 2020

Intravenous cisplatin, doxorubicin, and cyclophosphamide in the treatment of uterine papillary serous carcinoma (UPSC)

1 reference

12 December 2020

Uterine papillary serous and clear cell carcinomas predict for poorer survival compared to grade 3 endometrioid corpus cancers

1 reference

12 December 2020

The relationship between histology and outcome in advanced and recurrent endometrial cancer patients participating in first-line chemotherapy trials: a Gynecologic Oncology Group study

1 reference

12 December 2020

Uterine serous carcinoma. A morphologically diverse neoplasm with unifying clinicopathologic features

1 reference

12 December 2020

Whole abdominal radiotherapy in the adjuvant treatment of patients with stage III and IV endometrial cancer: a gynecologic oncology group study

1 reference

12 December 2020

Prognosis of papillary serous, clear cell, and grade 3 stage I carcinoma of the endometrium.

1 reference

12 December 2020

Stage IA uterine serous carcinoma: a study of 13 cases

1 reference

12 December 2020

Significance of comprehensive surgical staging in noninvasive papillary serous carcinoma of the endometrium.

1 reference

12 December 2020

Uterine papillary serous carcinoma (UPSC) treated with cisplatin, doxorubicin, and cyclophosphamide (PAC)

1 reference

12 December 2020

Two pathogenetic types of endometrial carcinoma

1 reference

12 December 2020

Uterine papillary serous carcinoma: comparisons of outcomes in surgical Stage I patients with and without adjuvant therapy

1 reference

12 December 2020

Outcomes in surgical stage I uterine papillary serous carcinoma

1 reference

12 December 2020

Endometrial intraepithelial carcinoma: a distinctive lesion specifically associated with tumors displaying serous differentiation

1 reference

12 December 2020

Randomized Phase III Trial of Whole-Abdominal Irradiation Versus Doxorubicin and Cisplatin Chemotherapy in Advanced Endometrial Carcinoma: A Gynecologic Oncology Group Study

1 reference

12 December 2020

Global expression changes of constitutive and hormonally regulated genes during endometrial neoplastic transformation

1 reference

12 December 2020

The aetiology of carcinoma of the body of the uterus

1 reference

12 December 2020

The use of paclitaxel and platinum-based chemotherapy in uterine papillary serous carcinoma

1 reference

12 December 2020

Her-2/neu overexpression and amplification in uterine papillary serous carcinoma

1 reference

12 December 2020

Phase III trial of doxorubicin plus cisplatin with or without paclitaxel plus filgrastim in advanced endometrial carcinoma: a Gynecologic Oncology Group Study

1 reference

12 December 2020

Occurrence of endometrial glandular dysplasia precedes uterine papillary serous carcinoma

1 reference

12 December 2020

A phase III trial of surgery with or without adjunctive external pelvic radiation therapy in intermediate risk endometrial adenocarcinoma: a Gynecologic Oncology Group study

1 reference

12 December 2020

Uterine papillary serous carcinoma: a highly malignant form of endometrial adenocarcinoma

1 reference

12 December 2020

Outcome after combined modality treatment for uterine papillary serous carcinoma: a study by the Rare Cancer Network (RCN).

1 reference

12 December 2020

A randomized phase III trial in advanced endometrial carcinoma of surgery and volume directed radiation followed by cisplatin and doxorubicin with or without paclitaxel: A Gynecologic Oncology Group study

1 reference

12 December 2020

Improved survival in surgical stage I patients with uterine papillary serous carcinoma (UPSC) treated with adjuvant platinum-based chemotherapy

1 reference

12 December 2020

p53 in endometrial cancer and its putative precursors: evidence for diverse pathways of tumorigenesis

1 reference

12 December 2020

Uterine papillary serous carcinoma treated with intraperitoneal cisplatin and intravenous doxorubicin and cyclophosphamide

1 reference

12 December 2020

Gene expression fingerprint of uterine serous papillary carcinoma: identification of novel molecular markers for uterine serous cancer diagnosis and therapy

1 reference

12 December 2020

Precursors of corpus carcinoma. Estrogens and adenomatous hyperplasia. 1947.

1 reference

12 December 2020

Uterine papillary serous carcinoma (UPSC): a single institution review of 129 cases

1 reference

12 December 2020

Cancer statistics, 2007

1 reference

12 December 2020

10.1007/S11912-008-0076-X

Identifiers

DOI

1 reference

19 August 2017

1 reference

PubMed ID

18928665